FrancophonIA/ELRC3.0 huggingface dataset:
English: The use of Sprimeo HCT during breast-feeding is not recommended.
Danish: Brug af Sprimeo HCT frarådes under amning.
English: Reproductive system and breast disorders Common:
Danish: Renal dysfunktion, akut nyresvigt Det reproduktive system og mammae Almindelig:
English: Sprimeo HCT is contraindicated in patients with severe renal impairment or anuria (see section 4.3).
Danish: Sprimeo HCT er kontraindiceret til patienter med svært nedsat nyrefunktion eller anuri (se pkt.
English: Sprimeo HCT is contraindicated in patients with severe hepatic impairment (see section 4.3).
Danish: Sprimeo HCT er kontraindiceret til patienter med stærkt nedsat leverfunktion (se pkt.
English: HOW TO TAKE SPRIMEO HCT
Danish: SÅDAN SKAL DU TAGE SPRIMEO HCT
English: Sprimeo HCT 150 mg/25 mg film-coated tablets
Danish: Sprimeo HCT 150 mg/25 mg filmovertrukne tabletter
English: Sprimeo HCT 300 mg/25 mg film-coated tablets
Danish: Sprimeo HCT 300 mg/25 mg filmovertrukne tabletter
English: Sprimeo HCT is not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.
Danish: Hvis du ønsker at amme, kan din læge vælge en anden behandling til dig.
English: What Sprimeo HCT contains - Each Sprimeo HCT 150 mg/12.5 mg film-coated tablet contains 150 mg aliskiren (as hemifumarate) and 12.5 mg hydrocholorothiazide.
Danish: Sprimeo HCT indeholder: - Hver Sprimeo HCT 150 mg/12,5 mg filmovertrukken tablet indeholder 150 mg aliskiren (som hemifumarat) og 12,5 mg hydrochlorthiazid.
English: Due to the hydrochlorothiazide component, Sprimeo HCT is contraindicated in patients with severe hepatic impairment (see sections 4.3 and 5.2).
Danish: På grund af indholdet af hydrochlorthiazid er Sprimeo HCT kontraindiceret til patienter med stærkt nedsat leverfunktion (se pkt.
English: The concomitant use of Sprimeo HCT with angiotensin II receptor blockers (ARB) or angiotensin converting enzyme inhibitors (ACEI) is contraindicated in patients with renal impairment (GFR < 60 ml/min/1.73 m2) (see sections 4.3, 4.4 and 5.2).
Danish: Samtidig brug af Sprimeo HCT og angiotensin-II-receptorblokkere (ARB) eller angiotensin-konverteringsenzym (ACE)-hæmmere er kontraindiceret hos patienter med nedsat nyrefunktion (GFR < 60 ml/min./1,73 m2) (se pkt.
English: Sprimeo HCT 300 mg /25 mg may be administered in patients whose blood pressure is not adequately controlled with aliskiren 300 mg or hydrochlorothiazide 25 mg alone or by Sprimeo HCT 300 mg/12.5 mg or Sprimeo HCT 150 mg/25 mg.
Danish: Sprimeo HCT 300 mg/25 mg kan gives til patienter, hvis blodtryk ikke er tilstrækkeligt behandlet med aliskiren 300 mg eller hydrochlorthiazid 25 mg anvendt alene eller med Sprimeo HCT 300 mg/12,5 mg eller Sprimeo HCT 150 mg/25 mg.
English: Sprimeo HCT 300 mg/12.5 mg film-coated tablets
Danish: Sprimeo HCT 300 mg/12,5 mg filmovertrukne tabletter
English: Sprimeo HCT 150 mg/12.5 mg film-coated tablets
Danish: Sprimeo HCT 150 mg/12,5 mg filmovertrukne tabletter
English: Sprimeo HCT 300 mg/12.5 mg film-coated tablets are violet white, oval film-coated tablets imprinted with “CVI” on one side and “NVR” on the other.
Danish: Sprimeo HCT 300 mg/12,5 mg filmovertrukne tabletter er violet-hvide, ovale, filmovertrukne tabletter, præget med ”CVI” på den ene side og ”NVR” på den anden.
English: Sprimeo HCT 150 mg/25 mg film-coated tablets are pale yellow, oval film-coated tablets imprinted with “CLL” on one side and “NVR” on the other.
Danish: Sprimeo HCT 150 mg/25 mg filmovertrukne tabletter er svagt gule, ovale, filmovertrukne tabletter, præget med ”CLL” på den ene side og ”NVR” på den anden.
English: Sprimeo HCT 150 mg /12.5 mg may be administered in patients whose blood pressure is not adequately controlled with aliskiren 150 mg or hydrochlorothiazide 12.5 mg alone.
Danish: Sprimeo HCT 150 mg/12,5 mg kan gives til patienter, hvis blodtryk ikke er tilstrækkeligt behandlet med aliskiren 150 mg eller hydrochlorthiazid 12,5 mg anvendt alene.
English: - Each Sprimeo HCT 300 mg/25 mg film-coated tablet contains 300 mg aliskiren (as hemifumarate) and 25 mg hydrocholorothiazide.
Danish: - Hver Sprimeo HCT 300 mg/25 mg filmovertrukken tablet indeholder 300 mg aliskiren (som hemifumarat) og 25 mg hydrochlorthiazid.
English: - Each Sprimeo HCT 300 mg/12.5 mg film-coated tablet contains 300 mg aliskiren (as hemifumarate) and 12.5 mg hydrocholorothiazide.
Danish: - Hver Sprimeo HCT 300 mg/12,5 mg filmovertrukken tablet indeholder 300 mg aliskiren (som hemifumarat) og 12,5 mg hydrochlorthiazid.
English: For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Danish: Hvis du vil have yderligere oplysninger om Sprimeo HCT, skal du henvende dig til den lokale repræsentant:
English: In sodium-depleted and/or volume-depleted patients, such as those receiving high doses of diuretics, symptomatic hypotension may occur after initiation of treatment with Sprimeo HCT.
Danish: Der kan opstå symptomatisk hypotension efter indledning af behandling med Sprimeo HCT hos patienter med væske- og/eller natriummangel, som fx patienter, der får høje doser diuretika.
English: Sprimeo HCT 300 mg/25 mg film-coated tablets are light yellow, oval film-coated tablets imprinted with “CVV” on one side and “NVR” on the other.
Danish: Sprimeo HCT 300 mg/25 mg filmovertrukne tabletter er lysegule, ovale, filmovertrukne tabletter, præget med ”CVV” på den ene side og ”NVR” på den anden.
English: Sprimeo HCT 150 mg /25 mg may be administered in patients whose blood pressure is not adequately controlled with aliskiren 150 mg or hydrochlorothiazide 25 mg alone or by Sprimeo HCT 150 mg/12.5 mg.
Danish: Sprimeo HCT 150 mg/25 mg kan gives til patienter, hvis blodtryk ikke er tilstrækkeligt behandlet med aliskiren 150 mg eller hydrochlorthiazid 25 mg anvendt alene eller med Sprimeo HCT 150 mg/12,5 mg.
English: - if you have experienced the following forms of angioedema (difficulties in breathing or swallowing, or swelling of the face, hands and feet, eyes, lips and/or tongue): angioedema when taking aliskiren hereditary angioedema angioedema without any known cause.
Danish: Hvis du mener, at du er allergisk, skal du ikke tage Sprimeo HCT og kontakte lægen for vejledning; - hvis du har oplevet følgende former for angioødem (svært ved at trække vejret eller synke eller har haft hævet ansigt, hænder og fødder, øjenomgivelser, læber og/eller tunge): angioødem når du har taget aliskiren.
English: Sprimeo HCT 300 mg/25 mg film-coated tablets Aliskiren/hydrochlorothiazide
Danish: Sprimeo HCT 300 mg/25 mg filmovertrukne tabletter Aliskiren/hydrochlorthiazid
English: Sprimeo HCT 300 mg /12.5 mg may be administered in patients whose blood pressure is not adequately controlled with aliskiren 300 mg or hydrochlorothiazide 12.5 mg alone or by Sprimeo HCT 150 mg/12.5 mg.
Danish: Sprimeo HCT 300 mg/12,5 mg kan gives til patienter, hvis blodtryk ikke er tilstrækkeligt behandlet med aliskiren 300 mg eller hydrochlorthiazid 12,5 mg anvendt alene eller med Sprimeo HCT 150 mg/12,5mg.
English: Sprimeo HCT 150 mg/12.5 mg film-coated tablets Aliskiren/hydrochlorothiazide
Danish: Sprimeo HCT 150 mg/12,5 mg filmovertrukne tabletter Aliskiren/hydrochlorthiazid
English: Sprimeo HCT 150 mg/25 mg film-coated tablets Aliskiren/hydrochlorothiazide
Danish: Sprimeo HCT 150 mg/25 mg filmovertrukne tabletter Aliskiren/hydrochlorthiazid
English: Sprimeo HCT 300 mg/12.5 mg film-coated tablets Aliskiren/hydrochlorothiazide
Danish: Sprimeo HCT 300 mg/12,5 mg filmovertrukne tabletter Aliskiren/hydrochlorthiazid
English: BEFORE YOU TAKE SPRIMEO HCT
Danish: DET SKAL DU VIDE, FØR DU BEGYNDER AT TAGE SPRIMEO HCT
English: - This medicine has been prescribed for you.
Danish: - Lægen har ordineret Sprimeo HCT til dig personligt.
English: What Sprimeo HCT looks like and contents of the pack Sprimeo HCT 150 mg/12.5 mg film-coated tablets are white, oval film-coated tablets imprinted with “LCI” on one side and “NVR” on the other.
Danish: Sprimeo HCT 150 mg/12,5 mg filmovertrukne tabletter er hvide, ovale, filmovertrukne tabletter, præget med ”LCI” på den ene side og ”NVR” på den anden.
English: Hypotension
Danish: Amning
English: CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT TO BE IMPLEMENTED BY THE MEMBER STATES
Danish: BILAG BETINGELSER ELLER BEGRÆNSNINGER MED HENSYN TIL EN SIKKER OG EFFEKTIV ANVENDELSE AF LÆGEMIDLET SKAL IMPLEMENTERES AF MEDLEMSLANDENE
English: The Member States must ensure that all conditions or restrictions with regard to the safe and effective use of the medicinal product described below are implemented in their national territory:
Danish: Medlemslandene skal sikre, at alle betingelser eller begrænsninger med hensyn til en sikker og effektiv anvendelse af lægemidlet, som beskrevet nedenfor, implementeres i deres nationale territorium:
English: ANNEX
Danish: Opbevaringsforhold
English: • Prior to launch of the product in the Member State, the national competent authority shall agree the content and format of the educational material with the Marketing Authorisation Holder
Danish: • Før præparatet markedsføres i medlemslandet, skal indehaveren af markedsføringstilladelsen nå til enighed om indholdet og formatet af uddannelsesmaterialet med den nationale kompetente myndighed
English: • The Marketing Authorisation Holder (MAH) should ensure that, at launch, all Healthcare Professionals who are expected to prescribe Cinryze are provided with an Educational pack.
Danish: • Indehaveren af markedsføringstilladelsen skal sikre, at alt sundhedspersonale, som forventes at ordinere Cinryze, forsynes med en uddannelsespakke på tidspunktet for markedsføring.
English: • Educational materials for non Healthcare Professionals
Danish: • Uddannelsesmateriale for personer, der ikke er sundhedspersonale
English: • Summary of Product Characteristics and Patient Information Leaflet for Cinryze
Danish: • Produktresumeet og indlægssedlen for Cinryze
English: The educational material for non Healthcare Professionals should include information on the following key elements:
Danish: Uddannelsesmaterialet for personer, der ikke er sundhedspersonale, skal indeholde information om de følgende nøgleelementer:
English: The training to be provided should address the following elements Precaution for storage
Danish: Den forsynede træning skal omhandle de følgende elementer Opbevaringsforhold
English: For some patients the prescribing physician may decide that Cinryze may be administered at home by a non Healthcare Professional such as a family member or by self-administration.
Danish: Den ordinerende læge kan for nogle patienter bestemme, at Cinryze kan indgives i hjemmet af personer, der ikke er sundhedspersonale, såsom et familiemedlem eller ved selvindgivelse.
English: The educational material for Healthcare Professionals should include information on the following key elements:
Danish: Uddannelsesmaterialet for sundhedspersonale skal indeholde information om de følgende nøgleelementer:
English: It is the responsibility of the prescribing physician to provide appropriate training to the nonhealthcare professional who will administer the treatment at home, such as the patient for selfadministration or a family member.
Danish: Det er den ordinerende læges ansvar at sørge for hensigtsmæssig træning af personer, der ikke er sundhedspersonale, som vil indgive behandlingen i hjemmet, såsom patienten, der skal indgive behandlingen til sig selv eller et familiemedlem.
English: Their prescribing physician will provide training on the following elements: Precaution for storage
Danish: Deres ordinerende læge vil forsyne dem med træning i de følgende elementer:
English: These issues were considered to be of serious public health concern.
Danish: Dette blev anset for at udgøre en risiko for folkesundheden.
English: London, 23 January 2008 EMEA/CHMP/350278/2007
Danish: London, den 23. januar 2008 EMEA/CHMP/350278/2007
English: The Reference Member State was United Kingdom and the Concerned Member States were Denmark, Finland, Norway and Sweden.
Danish: Referencemedlemsstaten var Det Forenede Kongerige, og de berørte medlemsstater var Danmark, Finland, Norge og Sverige.
English: The Mutual Recognition Procedure started on 15 November 2005.
Danish: Den gensidige anerkendelsesprocedure indledtes den 15. november 2005.
English: These Member States were not able to reach an agreement with respect to the Mutual Recognition of the Marketing Authorisation granted by the Reference Member State.
Danish: Disse medlemsstater kunne ikke nå til enighed om en gensidig anerkendelse af den markedsføringstilladelse, som referencemedlemsstaten havde udstedt.
English: The arbitration procedure started on 1 June 2006 with the adoption of a list of questions.
Danish: Voldgiftsproceduren indledtes den 1. juni 2006 med vedtagelsen af en liste med spørgsmål.
English: The final opinion was converted into a Decision by the European Commission on 18 January 2008.
Danish: Den endelige udtalelse blev konverteret til en afgørelse af Europa-Kommissionen den 18. januar 2008.
English: United Kingdom referred the reasons for disagreement to the EMEA on 5 May 2006.
Danish: Det Forenede Kongerige fremsendte begrundelserne for uenigheden til EMEA den 5. maj 2006.
English: The Rapporteur was Dr Hudson and Co-Rapporteur(s) was Dr Ljungberg.
Danish: Rapportør var dr. Hudson, og medrapportør var dr. Ljungberg.
English: The Marketing Authorisation Holder provided written explanations on 21 September 2006.
Danish: Indehaveren af markedsføringstilladelsen indsendte skriftlige redegørelser den 21. september 2006.
English: A positive opinion was adopted by consensus on 16 November 2006.
Danish: Udvalget vedtog ved konsensus en positiv udtalelse den 16. november 2006.
English: The list of the product names concerned is given in Annex I. The scientific conclusions are provided in Annex II, together with the Summary of Product Characteristics in Annex III.
Danish: Listen over de pågældende produktnavne fremgår af bilag I. De faglige konklusioner findes i bilag II sammen med produktresuméet i bilag III.
English: The proposed dosage regimen for complicated urinary tract infections (100 mg bid) was considered too low and should be changed to 200-400 mg twice daily.
Danish: Det foreslåede doseringsregime for kompliceret urinvejsinfektion (100 mg to gange dagligt) blev anset for at være for lavt og burde ændres til 200-400 mg to gange dagligt.
English: On 21 June 2007 the CHMP, in order to focus and facilitate the translations of the specific amendments in the Summary of Product Characteristics, adopted a revised opinion with amended Annex II and Annex III, which was further reconsidered in October 2007.
Danish: Med henblik på at fokusere og lette oversættelserne af de specifikke ændringer i produktresuméet vedtog CHMP den 21. juni 2007 en revideret udtalelse med ændring af bilag II og bilag III, som blev taget op til fornyet overvejelse i oktober 2007.
English: Significant differences were identified with regards to the approved posology for complicated urinary tract infections and the maximum daily dose for this generic intravenous ciprofloxacin product.
Danish: Der blev konstateret betydelige forskelle med hensyn til den godkendte dosering ved kompliceret urinvejsinfektion og den maksimale daglige dosis for dette generiske ciprofloxacinprodukt til intravenøs anvendelse.
English: Nycomed Danmark ApS submitted applications for mutual recognition of Ciprofloxacin Nycomed and associated names, 2 mg/ml Solution for Infusion, on the basis of the marketing authorisation granted by United Kingdom on 23 March 2005.
Danish: Nycomed Danmark ApS indgav ansøgninger om gensidig anerkendelse af Ciprofloxacin Nycomed og tilknyttede navne, 2 mg/ml infusionsvæske, opløsning, på grundlag af den markedsføringstilladelse, som Det Forenede Kongerige udstedte den 23. marts 2005.
English: During their 13-16 November 2006 meeting, the CHMP, in the light of the overall data submitted and the scientific discussion within the Committee, was of the opinion that the benefit/risk ratio is favourable for Ciprofloxacin Nycomed and associated names, that the objections raised by Norway and Sweden should not prevent the granting of a Marketing Authorisation and that the Summary of Product Characteristics, labelling and package leaflet of the Reference Member State should be amended.
Danish: På sit møde den 13.-16. november 2006 var CHMP på grundlag af de forelagte oplysninger og den faglige drøftelse i udvalget af den opfattelse, at benefit/risk-forholdet for Ciprofloxacin Nycomed og tilknyttede navne er gunstigt, at indsigelserne, der var rejst af Norge og Sverige, ikke bør være til hinder for udstedelsen af en markedsføringstilladelse, og at referencemedlemsstatens produktresumé, etikettering og indlægsseddel bør ændres.
English: Ciprofloxacin Nycomed and associated names, 2 mg/ml Solution for Infusion, is an antibiotic belonging to the quinolone family effective in vitro against a large number of Gram-negative aerobic bacteria as well as against some Gram-positive organisms.
Danish: Ciprofloxacin Nycomed og tilknyttede navne, 2 mg/ml infusionsvæske, opløsning, er et antibiotikum, der hører til quinolon-gruppen, og som in vitro har vist sig at have en virkning mod en lang række gramnegative aerobe bakterier og mod visse grampositive organismer.
English: Further, as patients referred to parenteral treatment often are seriously ill, it was felt of importance that a maximum dosage of 1200 mg (400 mg three times daily) instead of 800 mg be permitted.
Danish: Derudover blev det anset for vigtigt at tillade en maksimal dosis på 1.200 mg (400 mg tre gange dagligt) i stedet for 800 mg, eftersom de patienter, der får ordineret parenteral behandling, ofte er alvorligt syge.
English: International Non-Proprietary Name (INN): Ciprofloxacin
Danish: UDVALGET FOR HUMANMEDICINSKE LÆGEMIDLER (CHMP) UDTALELSE SOM FØLGE AF EN SAG INDBRAGT I HENHOLD TIL ARTIKEL 29, STK. 41, OM Ciprofloxacin Nycomed og tilknyttede navne Internationalt fællesnavn (INN): Ciprofloxacin
English: • If you are not eating enough.
Danish: • hvis du ikke spiser tilstrækkeligt.
English: The end of the observation period was 36 hours.
Danish: Observationsperioden blev afsluttet efter 36 timer.
English: Date of first authorisation: 27 June 2000 Date of latest renewal: 17 February 2015
Danish: Dato for første markedsføringstilladelse: 27. juni 2000 Dato for seneste fornyelse: 17. februar 2015
English: Do not leave your insulin in a car on an exceptionally warm or cold day.
Danish: Efterlad ikke din insulin i en bil på særligt varme eller kolde dage.
English: Treatment in combination with
Danish: Behandling i kombination med
English: The target audience and the modalities for distribution of all of these materials are to be agreed at Member State Level.
Danish: Målgruppen og bestemmelserne for distribution af alle disse materialer skal aftales på medlemsstatsplan.
English: This is because you will not be able to read the dose window on the pen.
Danish: Dette skyldes, at du ikke vil være i stand til at læse doseringsvinduet på pennen.
English: If you have “Type 1” diabetes and you have an illness or injury:
Danish: Hvis du har ”type 1”-diabetes og du er syg eller skadet:
English: Component of a multipack, can't be sold separately.
Danish: Enkeltdele af en multipakke, kan ikke sælges separat.
English: ATC Code: A10A E04.
Danish: ATC-kode: A10AE04.
English: Always tell people who are caring or treating you, that you have diabetes.
Danish: Fortæl altid de personer, som passer eller behandler dig, at du har diabetes.
English: Always perform a safety test
Danish: Udfør altid en sikkerhedstest
English: Each pen contains more than one dose.
Danish: Hver pen indeholder mere end en dosis.
English: The educational materials consist of:
Danish: Undervisningsmaterialet består af:
English: (see section 6.6).
Danish: (angivet i punkt 6).
English: • Only use your pen for up to 6 weeks after its first use.
Danish: • Brug kun pennen i op til 6 uger efter første anvendelse.
English: Discard the pen after this time period.
Danish: Bortskaf pennen efter denne periode.
English: Take a new pen out of the fridge at least 1 hour before you inject.
Danish: Tag en ny pen ud af køleskabet mindst 1 time før du skal injicere.
English: Flexibility in dosing time
Danish: Fleksibilitet i doseringstid
English: You can change the time of your injection if you need to.
Danish: Du kan ændre injektionstidspunktet, hvis det er nødvendigt.
English: • Skin changes at the injection site:
Danish: • Hudforændringer på injektionsstedet:
English: Having too low or too high blood sugar or sight problems can affect your ability to drive and use tools or machines.
Danish: For lavt eller for højt blodsukker eller synsproblemer kan påvirke din evne til at køre og bruge værktøj eller maskiner.
English: STEP 1: Check your pen
Danish: TRIN 1: Kontroller din pen
English: • You can see roughly how many units of insulin are left by looking at where the plunger is on the insulin scale.
Danish: • Du kan se nogenlunde hvor mange enheder insulin, der er tilbage ved at se på, hvor stemplet er på insulinskalaen.
English: It is used for once daily dosing.
Danish: Det bruges til dosering en gang daglig.
English: Please, consult your doctor for further information.
Danish: Kontakt din læge for flere oplysninger.
English: Generally, the greater and more rapid the decline in blood glucose, the more marked is the phenomenon of counter-regulation and its symptoms.
Danish: Generelt gælder det, at jo større og hurtigere faldet i blodglucosen er, des mere udtalt er modregulationstilstanden og dens symptomer.
English: Steady state level within the therapeutic range is reached after 3-4 days of daily Toujeo administration.
Danish: Steady state-niveau inden for det terapeutiske område opnås efter 3-4 dages daglig administration af Toujeo.
English: Fertility Animal studies do not indicate direct harmful effects with respect to fertility.
Danish: Fertilitet Dyrestudier viser ingen direkte skadelig effekt med hensyn til fertilitet.
English: Patients in the Toujeo arm included 73 children aged <12 years and 160 children aged ≥12 years.
Danish: Patienter i Toujeo-armen inkluderede 73 børn i alderen <12 år og 160 børn i alderen ≥ 12 år.
English: Toujeo SoloStar 30 months.
Danish: Toujeo SoloStar 30 måneder.
English: This medicine should not be used in children under 6 years of age.
Danish: Denne medicin skal ikke bruges til børn under 6 år.
English: Never use your pen if it is damaged or if you are not sure that it is working properly.
Danish: Anvend aldrig pennen, hvis den er beskadiget eller hvis du er usikker på, om den virker korrekt.
English: Take about 10 to 20 grams sugar straight away - such as glucose, sugar cubes or a sugary-drink.
Danish: Tag omgående ca. 10-20 g sukker f.eks. som glucose, hugget sukker eller en sukkersødet drik.
English: These injections should be given even if it is not certain that you have hypoglycaemia.
Danish: Det er forsvarligt at give disse injektioner, også selv om det ikke er sikkert, at du har hypoglykæmi.
English: The scale on most syringes is made for non-concentrated insulin only.
Danish: Skalaen på de fleste sprøjter er kun lavet til ikke-koncentreret insulin.
English: If you find it difficult to recognise your warning signs, you should avoid situations (such as driving a car) in which you or others would be put at risk by hypoglycaemia.
Danish: Hvis du har svært ved at genkende dine advarselssymptomer, bør du undgå situationer (såsom bilkørsel), hvor du selv eller andre kan bringes i fare på grund af risikoen for hypoglykæmi.
English: In the following situations, the management of your diabetes may require extra care (for example, blood and urine tests):
Danish: I følgende situationer kan kontrollen af din diabetes kræve ekstra opmærksomhed (for eksempel blodog urinprøver):
English: • Guide for healthcare professionals
Danish: • Vejledning til sundhedspersonalet
English: Using a new sterile needle for each injection also minimizes the risk of contamination and infection.
Danish: Brug af en ny steril nål til hver injektion minimerer også risikoen for kontaminering og infektion.